Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.41 |
| ▸ | CA1 known ✓ | P00915 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7207850 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL7098262 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL626430 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL7096164 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL223461 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL7095267 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL7098222 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL9651092 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL7100030 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 | |
| SCHEMBL472819 | 1.00 | CA2 (0.41) | CA2CA1CYP3A4TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115196980-A | Preparation method of magnesia-carbon refractory castable | 偃师中岳耐火材料有限公司 | 2022-10-18 | — | — | CN | disclosed |
| US-20180163056-A1 | HYDROPHILIC CURABLE COMPOSITIONS | MITSUI CHEMICALS, INC. (JP) | 2018-06-14 | — | — | US | disclosed |
| US-20180036995-A1 | HYDROPHILIC MONOLAYER FILM WITH OPTICAL FUNCTIONALITY AND STACK OF THE SAME | MITSUI CHEMICALS, INC. (JP) | 2018-02-08 | — | — | US | disclosed |
| EP-3270192-A1 | HYDROPHILIC SINGLE-LAYER FILM HAVING OPTICAL FUNCTIONALITY, AND LAMINATE THEREOF | Mitsui Chemicals, Inc. (JP) | 2018-01-17 | — | — | EP | disclosed |
| US-20170209345-A1 | DENTAL PROSTHESIS | MITSUI CHEMICALS, INC. (JP) | 2017-07-27 | — | — | US | disclosed |
| EP-3081578-A1 | COMPOSITION FOR HYDROPHILIC CURED PRODUCT | Mitsui Chemicals, Inc. (JP) | 2016-10-19 | — | — | EP | disclosed |
| EP-2648921-B1 | TRANSPARENT INK-JET RECORDING FILMS | CARESTREAM HEALTH INC (US) | 2015-11-04 | — | — | EP | disclosed |
| EP-2629981-B1 | TRANSPARENT INK- JET RECORDING FILMS | CARESTREAM HEALTH INC (US) | 2015-08-05 | — | — | EP | disclosed |
| EP-2625042-B1 | TRANSPARENT INK-JET RECORDING FILMS, COMPOSITIONS, AND METHODS | CARESTREAM HEALTH INC (US) | 2015-07-08 | — | — | EP | disclosed |
| EP-2741921-A1 | TRANSPARENT INK-JET RECORDING FILMS | Carestream Health, Inc. (US) | 2014-06-18 | — | — | EP | disclosed |
| US-6165699-A | Annealed adhesion promoting layer for photographic imaging elements | EASTMAN KODAK COMPANY (US) | 2000-12-26 | — | — | US | disclosed |
| US-6162597-A | POLYVINYL ACETAL BINDER; ADHESIVE GLYCIDYL INTERLAYER BONDING POLYESTER SUPPORT | EASTMAN KODAK COMPANY (US) | 2000-12-19 | — | — | US | disclosed |
| EP-0672620-B1 | Process for reducing the moisture content of alumina trihydrate | CYTEC TECH CORP (US) | 1997-10-29 | — | — | EP | disclosed |
| EP-0672620-A1 | Process for reducing the moisture content of alumina trihydrate | CYTEC TECHNOLOGY CORP. (US) | 1995-09-20 | — | — | EP | disclosed |
| US-5451329-A | Sulfosuccinate and oil | CYTEC TECHNOLOGY CORP. (US) | 1995-09-19 | — | — | US | disclosed |
| US-4328283-A | Photographic polyester supports subjected to subbing treatment | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1982-05-04 | — | — | US | disclosed |
| US-4230746-A | SULFATE FOAMING AGENT, TERTIARY AMINE OR QUATERNARY SALT DISPERSANT, SULFOSUCCINATE STABILIZER | GAF CORPORATION (US) | 1980-10-28 | — | — | US | disclosed |
| US-4208485-A | ORGANIC SULFATE, SULFOSUCCINIC ACID DERIVATIVES, AND AN ALKYLENEOXY AMINE | GAF CORPORATION (US) | 1980-06-17 | — | — | US | disclosed |
| US-4198316-A | Foaming composition for textile finishing and coatings | GAF CORPORATION (US) | 1980-04-15 | — | — | US | disclosed |
| US-4158623-A | CONDITIONING AN AQUEOUS SLURRY WITH A FATTY ACID AND A DIALKYL SULFOSUCCINATE | AMERICAN CYANAMID COMPANY (US) | 1979-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170209345-A1 | DENTAL PROSTHESIS | CAD, OR10J3, PSMA3 | CA2 168/4885CA1 5/4885CYP3A4 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.